Recognize TM

Our technology is based on InnoTech’s patented diagnostic platform for rapid, simultaneous and multiomics detection of several different classes of disease biomarkers.  This is based on our proprietary workflow and chemistry with disease specific all enclosed microfluidic cartridges.

Why simultaneous detection?

Genotype provides information about predisposition to a disease or the presence of a disease agent or its remnants, but it may not provide information about whether the individual suffers from the disease. A phenotypic biomarker could bridge the gap to provide a complete picture of the disease state.

Our Patent

InnoTech Precision Medicine’s patented technology allows multiplexing for detection of genotypic and phenotypic biomarkers on a single specimen using a microfluidic cartridge.